Lower concentrations of AMD3100 were required to inhibit infection of cells expressing low levels of CXCR4 (MYA-1) than high levels of CXCR4 (CLL-CD134). This evidence concerns the gene TNFRSF4 and B-cell chronic lymphocytic leukemia.